FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090976193> ?p ?o ?g. }

• W2090976193 endingPage "169" @default.
• W2090976193 startingPage "163" @default.
• W2090976193 abstract "The main function of Erythropoietin (EPO) and its receptor (EPOR) is the stimulation of erythropoiesis. Recombinant human EPO (rhEPO) is therefore used to treat anemia in cancer patients. However, clinical trials have indicated that rhEPO treatment might promote tumor progression and has a negative effect on patient survival. In addition, EPOR expression has been detected in several cancer forms. Using a newly produced anti-EPOR antibody that reliably detects the full-length isoform of the EPOR we show that breast cancer tissue and cells express the EPOR protein. rhEPO stimulation of cultured EPOR expressing breast cancer cells did not result in increased proliferation, overt activation of EPOR (receptor phosphorylation) or a consistent activation of canonical EPOR signaling pathway mediators such as JAK2, STAT3, STAT5, or AKT. However, EPOR knockdown experiments suggested functional EPO receptors in estrogen receptor positive (ERα+) breast cancer cells, as reduced EPOR expression resulted in decreased proliferation. This effect on proliferation was not seen in ERα negative cells. EPOR knockdown decreased ERα activity further supports a mechanism by which EPOR affects proliferation via ERα-mediated mechanisms. We show that EPOR protein is expressed in breast cancer cells, where it appears to promote proliferation by an EPO-independent mechanism in ERα expressing breast cancer cells." @default.
• W2090976193 created "2016-06-24" @default.
• W2090976193 creator A5017330034 @default.
• W2090976193 creator A5018738617 @default.
• W2090976193 creator A5029981922 @default.
• W2090976193 creator A5044589772 @default.
• W2090976193 creator A5051135936 @default.
• W2090976193 creator A5059094500 @default.
• W2090976193 creator A5081536466 @default.
• W2090976193 creator A5083737061 @default.
• W2090976193 creator A5089265727 @default.
• W2090976193 date "2014-02-01" @default.
• W2090976193 modified "2023-10-17" @default.
• W2090976193 title "EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation" @default.
• W2090976193 cites W1576846200 @default.
• W2090976193 cites W1884631150 @default.
• W2090976193 cites W1980243061 @default.
• W2090976193 cites W1982265866 @default.
• W2090976193 cites W1995521762 @default.
• W2090976193 cites W1995713439 @default.
• W2090976193 cites W1997122023 @default.
• W2090976193 cites W2004543321 @default.
• W2090976193 cites W2024257379 @default.
• W2090976193 cites W2031980124 @default.
• W2090976193 cites W2032960954 @default.
• W2090976193 cites W2043981867 @default.
• W2090976193 cites W2051066066 @default.
• W2090976193 cites W2059175990 @default.
• W2090976193 cites W2087291116 @default.
• W2090976193 cites W2094233124 @default.
• W2090976193 cites W2103548416 @default.
• W2090976193 cites W2121155074 @default.
• W2090976193 cites W2141554428 @default.
• W2090976193 cites W2162885883 @default.
• W2090976193 cites W2171518347 @default.
• W2090976193 cites W2336116827 @default.
• W2090976193 cites W4256003647 @default.
• W2090976193 doi "https://doi.org/10.1016/j.bbrc.2014.01.165" @default.
• W2090976193 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24502950" @default.
• W2090976193 hasPublicationYear "2014" @default.
• W2090976193 type Work @default.
• W2090976193 sameAs 2090976193 @default.
• W2090976193 citedByCount "14" @default.
• W2090976193 countsByYear W20909761932014 @default.
• W2090976193 countsByYear W20909761932015 @default.
• W2090976193 countsByYear W20909761932016 @default.
• W2090976193 countsByYear W20909761932017 @default.
• W2090976193 countsByYear W20909761932019 @default.
• W2090976193 countsByYear W20909761932021 @default.
• W2090976193 countsByYear W20909761932022 @default.
• W2090976193 crossrefType "journal-article" @default.
• W2090976193 hasAuthorship W2090976193A5017330034 @default.
• W2090976193 hasAuthorship W2090976193A5018738617 @default.
• W2090976193 hasAuthorship W2090976193A5029981922 @default.
• W2090976193 hasAuthorship W2090976193A5044589772 @default.
• W2090976193 hasAuthorship W2090976193A5051135936 @default.
• W2090976193 hasAuthorship W2090976193A5059094500 @default.
• W2090976193 hasAuthorship W2090976193A5081536466 @default.
• W2090976193 hasAuthorship W2090976193A5083737061 @default.
• W2090976193 hasAuthorship W2090976193A5089265727 @default.
• W2090976193 hasBestOaLocation W20909761931 @default.
• W2090976193 hasConcept C121608353 @default.
• W2090976193 hasConcept C126322002 @default.
• W2090976193 hasConcept C134018914 @default.
• W2090976193 hasConcept C170493617 @default.
• W2090976193 hasConcept C173396325 @default.
• W2090976193 hasConcept C2778534260 @default.
• W2090976193 hasConcept C2779391668 @default.
• W2090976193 hasConcept C31102739 @default.
• W2090976193 hasConcept C502942594 @default.
• W2090976193 hasConcept C530470458 @default.
• W2090976193 hasConcept C54355233 @default.
• W2090976193 hasConcept C62112901 @default.
• W2090976193 hasConcept C62478195 @default.
• W2090976193 hasConcept C71924100 @default.
• W2090976193 hasConcept C81885089 @default.
• W2090976193 hasConcept C84606932 @default.
• W2090976193 hasConcept C86803240 @default.
• W2090976193 hasConcept C95444343 @default.
• W2090976193 hasConceptScore W2090976193C121608353 @default.
• W2090976193 hasConceptScore W2090976193C126322002 @default.
• W2090976193 hasConceptScore W2090976193C134018914 @default.
• W2090976193 hasConceptScore W2090976193C170493617 @default.
• W2090976193 hasConceptScore W2090976193C173396325 @default.
• W2090976193 hasConceptScore W2090976193C2778534260 @default.
• W2090976193 hasConceptScore W2090976193C2779391668 @default.
• W2090976193 hasConceptScore W2090976193C31102739 @default.
• W2090976193 hasConceptScore W2090976193C502942594 @default.
• W2090976193 hasConceptScore W2090976193C530470458 @default.
• W2090976193 hasConceptScore W2090976193C54355233 @default.
• W2090976193 hasConceptScore W2090976193C62112901 @default.
• W2090976193 hasConceptScore W2090976193C62478195 @default.
• W2090976193 hasConceptScore W2090976193C71924100 @default.
• W2090976193 hasConceptScore W2090976193C81885089 @default.
• W2090976193 hasConceptScore W2090976193C84606932 @default.
• W2090976193 hasConceptScore W2090976193C86803240 @default.
• W2090976193 hasConceptScore W2090976193C95444343 @default.
• W2090976193 hasIssue "1" @default.

• next